Coloplast A/S (Coloplast A/S) Total Liabilities : $4,896 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Coloplast A/S Total Liabilities?

Coloplast A/S's Total Liabilities for the quarter that ended in Dec. 2023 was $4,896 Mil.

Coloplast A/S's quarterly Total Liabilities increased from Jun. 2023 ($4,161.44 Mil) to Sep. 2023 ($4,416.33 Mil) and increased from Sep. 2023 ($4,416.33 Mil) to Dec. 2023 ($4,896.41 Mil).

Coloplast A/S's annual Total Liabilities increased from Sep. 2021 ($1,213.97 Mil) to Sep. 2022 ($3,878.41 Mil) and increased from Sep. 2022 ($3,878.41 Mil) to Sep. 2023 ($4,416.33 Mil).

Coloplast A/S Total Liabilities Historical Data

The historical data trend for Coloplast A/S's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Total Liabilities Chart

Coloplast A/S Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Total Liabilities

Get a 7-Day Free Trial

858.45

964.86

1,213.97

3,878.41

4,416.33

Coloplast A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															4,174.34	4,066.05	4,161.44	4,416.33	4,896.41

Coloplast A/S Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Coloplast A/S's Total Liabilities for the fiscal year that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2334.244	+	(1749.073	+	315.27
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	17.745)
	=	4,416

Total Liabilities	=	Total Assets (A: Sep. 2023 )	-	Total Equity (A: Sep. 2023 )
	=	6891.967	-	2475.636
	=	4,416

Coloplast A/S's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2767.894	+	(1786.3	+	322.905
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	19.313)
	=	4,896

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	7109.352	-	2212.94
	=	4,896

Coloplast A/S Total Liabilities Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Coloplast A/S (Coloplast A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (OTCPK:CLPBF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

CLPBY:USA COLOBc:UK 0QBO:UK COLO B:Denmark CBHD:Germany

Address

Holtedam 1-3, Humlebaek, DNK, DK-3050

Website

https://www.coloplast.com

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (Coloplast A/S) Headlines

From GuruFocus

Coloplast A/S's Dividend Analysis

By GuruFocus Research • 12-07-2023